Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pilot, Open-Label, Phase 2, Single-Center, Repeat Dose, Proof-of-Concept Safety, Pharmacodynamics and Efficacy Study of Orally Administered Dapansutrile Capsules in Subjects with Schnitzler's Syndrome (Een Pilot, Open-Label, Phase 2, Single-Center, Repeat Dose, Proof-of-Concept Safety naar Farmacodynamiek en Efficacy van Oraal Toegediende Dapansutrile Capsules bij PatiËnten met het syndroom van Schnitzler)

Next Previous
Search
Trial Profile

A Pilot, Open-Label, Phase 2, Single-Center, Repeat Dose, Proof-of-Concept Safety, Pharmacodynamics and Efficacy Study of Orally Administered Dapansutrile Capsules in Subjects with Schnitzler's Syndrome (Een Pilot, Open-Label, Phase 2, Single-Center, Repeat Dose, Proof-of-Concept Safety naar Farmacodynamiek en Efficacy van Oraal Toegediende Dapansutrile Capsules bij PatiËnten met het syndroom van Schnitzler)

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 07 Feb 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dapansutrile (Primary)
  • Indications Schnitzler syndrome
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Sponsors Olatec Therapeutics

    • Most Recent Events

    • 31 Jan 2024 Status changed from recruiting to discontinued.
    • 01 Jul 2021 Planned End Date changed from 31 May 2021 to 28 Feb 2023.
    • 01 Jul 2021 Planned primary completion date changed from 30 Mar 2021 to 30 Dec 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top